Exo-Tox outperforms traditional methods in identifying bacterial exotoxins, suggesting the need for specialized approaches.
Background Bacterial exotoxins are secreted proteins able to affect target cells, and associated with diseases. Their accurate identification can enhance drug discovery and ensure the safety of bacteria-based medical applications. However, current toxin predictors prioritize broad coverage by mixing toxins from multiple biological kingdoms and diverse control sets. This general approach has proven sub-optimal for identifying niche toxins, such as bacterial exotoxins. Recent Protein Language Models offer an opportunity to improve toxin prediction by capturing global sequence context and biochemical properties from protein sequences. Results We introduce Exo-Tox, a specialized predictor trained exclusively on curated datasets of bacterial exotoxins and secreted non-toxic bacterial proteins, represented as embeddings by Protein Language Models. Compared to Basic Local Alignment Search Tool (BLAST)-based methods and generalized toxin predictors, Exo-Tox outperforms across multiple metrics, achieving a Matthews correlation coefficient > 0.9. Notably, Exo-Tox’s performance remains robust regardless of protein length or the presence of signal peptides. We analyze its limited transferability to bacteriophage proteins and non-secreted proteins. Conclusion Exo-Tox reliably identifies bacterial exotoxins, filling a niche overlooked by generalized predictors. Our findings highlight the importance of domain-specific training data and emphasize that specialized predictors are necessary for accurate classification. We provide open access to the model, training data, and usage guidelines via the LMU Munich Open Data repository.
No takes yet. Share an insight, caveat, or question.
Krueger et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: